Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape
Authors:
Top Cited Papers
Open Access
- 20 February 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1765843
Abstract
Introduction: Cutaneous leishmaniasis (CL) is a skin disease caused by Leishmania infection, for which no licensed human vaccine exists. Protective immunity is largely T cell–mediated and depends on antigen presentation by MHC molecules, yet the naturally presented epitopes during human disease remain poorly defined. Methods: To address this gap, we performed mass spectrometry–based immunopeptidomics on lesional biopsies from 27 Ethiopian CL patients spanning the full clinical spectrum. Results: We newly identified 333 MHC-I and 247 MHC-II epitopes from 398 L. aethiopica proteins, including 19 peptides and 51 antigens recurrently presented across patients of which several were also epitope-rich. Some peptides were also detected during early infection in a L. aethiopica –infected THP-1 monocyte model, highlighting their relevance from disease onset. Notably, despite the broad predictive coverage of NetMHCpan and NetMHCIIpan, these tools missed 20–70% of the naturally presented epitopes while predicting millions of candidates, underscoring the limitations of prediction-only vaccine pipelines. Discussion: This first comprehensive map of the Leishmania immunopeptidome in human disease reveals conserved and prevalent antigens that can inform rational vaccine design and deepen our understanding of protective T cell responses in leishmaniasis.Keywords
This publication has 54 references indexed in Scilit:
- Exploring the dynamic landscape of immunopeptidomics: Unravelling posttranslational modifications and navigating bioinformatics terrainMass Spectrometry Reviews, 2024
- Machine learning‐based peptide‐spectrum match rescoring opens up the immunopeptidomeProteomics, 2023
- Combined assessment of MHC binding and antigen abundance improves T cell epitope predictionsiScience, 2022
- Identification of HLA-I restricted epitopes in six vaccine candidates of Leishmania tropica using immunoinformatics and molecular dynamics simulation approachesInfection, Genetics and Evolution, 2019
- Cutaneous Leishmaniasis Due to Leishmania aethiopicaeClinicalMedicine, 2018
- CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the uglySeminars in Immunopathology, 2015
- The major surface protease (MSP or GP63) in the intracellular amastigote stage of Leishmania chagasiMolecular and Biochemical Parasitology, 2008
- Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c miceMicrobes and Infection, 2007
- Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cellsEuropean Journal of Immunology, 1996
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989